Abstract
Objective: Geldanamycin induces degradation of Hsp90 client proteins, which may promote the presentation of degradation peptide with MHC class I on cancer cells. We hypothesized that geldanamycin may enhance the efficacy of DNA vaccine, and investigated the therapeutic effect of the combination of geldanamycin and DNA vaccine against Hsp90 client p185neu and Met
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
